Terms: = Lung cancer AND BTG1, P62324, 694, ENSG00000133639 AND Prognosis
32 results:
1. Effect of Behavioral Health Disorders on Surgical Outcomes in cancer Patients.
Katayama ES; Woldesenbet S; Munir MM; Endo Y; Rawicz-Pruszyński K; Khan MMM; Tsilimigras D; Dillhoff M; Cloyd J; Pawlik TM
J Am Coll Surg; 2024 Apr; 238(4):625-633. PubMed ID: 38420963
[TBL] [Abstract] [Full Text] [Related]
2. [Analysis of Clinicopathological Features on Spread Through Air Spaces
of lung Adenocarcinoma].
Fan L; Qin J; Lin X; Wu Y; He Z; He P
Zhongguo Fei Ai Za Zhi; 2023 Sep; 26(9):650-658. PubMed ID: 37985151
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy.
Zhang L; Zhao K; Kuang T; Wang K; Chai D; Qiu Z; Liu R; Deng W; Wang W
BMC Cancer; 2023 Jan; 23(1):101. PubMed ID: 36717809
[TBL] [Abstract] [Full Text] [Related]
4. Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIs.
Du X; Bai H; Wang Z; Daun J; Liu Z; Xu J; Chang G; Zhu Y; Wang J
Thorac Cancer; 2022 May; 13(9):1289-1298. PubMed ID: 35347870
[TBL] [Abstract] [Full Text] [Related]
5. An Inflammation-Related Nine-Gene Signature to Improve prognosis Prediction of lung Adenocarcinoma.
Liu ZJ; Hou PX; Wang XX
Dis Markers; 2021; 2021():9568057. PubMed ID: 34580602
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study.
Mao W; Fu Z; Wang K; Wu J; Xu B; Chen M
Ann Palliat Med; 2021 Mar; 10(3):2791-2804. PubMed ID: 33549017
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract] [Full Text] [Related]
8. The Management of Neuroendocrine Tumors of the lung in MEN1: Results From the Dutch MEN1 Study Group.
van den Broek MFM; de Laat JM; van Leeuwaarde RS; van de Ven AC; de Herder WW; Dekkers OM; Drent ML; Kerstens MN; Bisschop PH; Havekes B; Hackeng WM; Brosens LAA; Vriens MR; Buikhuisen WA; Valk GD
J Clin Endocrinol Metab; 2021 Jan; 106(2):e1014-e1027. PubMed ID: 33135721
[TBL] [Abstract] [Full Text] [Related]
9. Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of lung Adenocarcinoma.
Fei H; Chen S; Xu C
Biomed Res Int; 2020; 2020():8931419. PubMed ID: 33062704
[TBL] [Abstract] [Full Text] [Related]
10. Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer.
Wu XT; Zhou JW; Pan LC; Ge T
J Int Med Res; 2020 May; 48(5):300060520925644. PubMed ID: 32425092
[TBL] [Abstract] [Full Text] [Related]
11. Validation of Eurolung risk models in a Japanese population: a retrospective single-centre analysis of 612 cases.
Nagoya A; Kanzaki R; Kanou T; Ose N; Funaki S; Minami M; Shintani Y; Tsutsui A; Suga S; Tajima T; Ohno Y; Okumura M
Interact Cardiovasc Thorac Surg; 2019 Nov; 29(5):722-728. PubMed ID: 31317181
[TBL] [Abstract] [Full Text] [Related]
12. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
13. Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals.
Li S; Yang R; Sun X; Miao S; Lu T; Wang Y; Wo Y; Jiao W
Gene; 2018 Dec; 679():398-404. PubMed ID: 30240883
[TBL] [Abstract] [Full Text] [Related]
14. Trends in incidence and associated risk factors of suicide mortality in patients with non-small cell lung cancer.
Zhou H; Xian W; Zhang Y; Chen G; Zhao S; Chen X; Zhang Z; Shen J; Hong S; Huang Y; Zhang L
Cancer Med; 2018 Aug; 7(8):4146-4155. PubMed ID: 29971970
[TBL] [Abstract] [Full Text] [Related]
15. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract] [Full Text] [Related]
16. Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.
Matsumoto T; Nagashio R; Ryuge S; Igawa S; Kobayashi M; Fukuda E; Goshima N; Ichinoe M; Jiang SX; Satoh Y; Masuda N; Murakumo Y; Saegusa M; Sato Y
Pathol Int; 2018 Apr; 68(4):232-240. PubMed ID: 29431238
[TBL] [Abstract] [Full Text] [Related]
17. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
[TBL] [Abstract] [Full Text] [Related]
18. Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related Considerations.
Spreafico F; Biasoni D; Lo Vullo S; Gandola L; D'Angelo P; Terenziani M; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Morosi C; Perotti D; Catania S; Bellani FF; Collini P;
J Urol; 2017 Nov; 198(5):1138-1145. PubMed ID: 28655531
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis.
Zeng P; Li H; Lu PH; Zhou LN; Tang M; Liu CY; Chen MB
Sci Rep; 2017 Jun; 7(1):4223. PubMed ID: 28652617
[TBL] [Abstract] [Full Text] [Related]
20. Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France.
Hurtaud A; Donnadieu A; Escalup L; Cottu PH; Baffert S
Breast; 2016 Dec; 30():73-79. PubMed ID: 27639032
[TBL] [Abstract] [Full Text] [Related]
[Next]
